JAKARTA - PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) recorded the top net profit margin among its 13 competitors during January-September 2024. The following is the net profit margin achievement of four issuers in the pharmaceutical industry with market capitalization (marketcap) above IDR 5 trillion per September 2024.

Based on the ata compiled by IDN Financials on Monday (9/12), PT Kalbe Farma Tbk (KLBF) recorded revenue of IDR 24.23 trillion and net profit of IDR 2.37 trillion. With this achievement, the net profit margin was 9.81%. Meanwhile, market capitalization (marketcap) is worth IDR 80.85 trillion.

SIDO posted revenue of IDR 2.62 trillion and net profit of IDR 778.11 billion. This issuer's net profit margin was recorded at 29.62%. The market capitalization value reached IDR 19.95 trillion.  

PT Tempo Scan Pacific Tbk (TSPC) recorded revenue of IDR 10.15 trillion and net profit of IDR 1.08 trillion. This issuer posted a net profit margin of around 10.67% and a market capitalization value of IDR 12.35 trillion.

Meanwhile, PT Soho Global Health Tbk (SOHO) posted revenue of IDR 7.47 trillion and net profit of IDR 341.44 billion. The net margin is 4.57% and the market cap is IDR 8.5 trillion. (LK/LM)